Oral Versus Parenteral Nutrition Support to Improve Protein Balance in Colorectal Surgical Patients

This study has been completed.
Sponsor:
Collaborators:
Montreal General Hospital
McGill University
Information provided by (Responsible Party):
Franco Carli, McGill University Health Center
ClinicalTrials.gov Identifier:
NCT01222208
First received: October 14, 2010
Last updated: February 3, 2012
Last verified: February 2012

October 14, 2010
February 3, 2012
March 2011
November 2011   (final data collection date for primary outcome measure)
Whole body protein balance [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Whole body protein balance (the difference between protein synthesis and protein breakdown) as assessed by the kinetics of a stable, non-radioactive, isotope tracer infusion of L-[1-13C] leucine
Whole body protein balance [ Time Frame: 10/01/2011 ] [ Designated as safety issue: No ]
Whole body protein balance (the difference between protein synthesis and protein breakdown) as assessed by the kinetics of a stable, non-radioactive, isotope tracer infusion of L-[1-13C] leucine
Complete list of historical versions of study NCT01222208 on ClinicalTrials.gov Archive Site
Synthesis rates of hepatic secretory proteins [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Synthesis rates of hepatic secretory proteins, including the classically positive acute phase reactant fibrinogen and the classically negative acute phase reactant albumin, as assessed by incorporation of the stable, non-radioactive, isotope tracer L-[2H5] phenylalanine into plasma Very Low Density Lipoprotein ApolipoproteinB100.
Synthesis rates of hepatic secretory proteins [ Time Frame: 10/01/2011 ] [ Designated as safety issue: No ]
Synthesis rates of hepatic secretory proteins, including the classically positive acute phase reactant fibrinogen and the classically negative acute phase reactant albumin, as assessed by incorporation of the stable, non-radioactive, isotope tracer L-[2H5] phenylalanine into plasma Very Low Density Lipoprotein ApolipoproteinB100.
Not Provided
Not Provided
 
Oral Versus Parenteral Nutrition Support to Improve Protein Balance in Colorectal Surgical Patients
Oral Versus Parenteral Perioperative Nutrition Support to Improve Protein Balance: Stable Isotope Study in Colorectal Surgical Patients

A prospective, randomized controlled study, using stable isotope methodology, is proposed to determine whether an oral nutrition support regimen, containing pressurized whey protein and glucose, is more effective at normalizing the metabolic response to surgery than a standard peripheral parenteral nutrition (PPN) support regimen, containing amino acids and glucose, in colorectal surgical patients studied before and after surgery. The effectiveness of the nutrition support regimens will be determined by: whole body protein balance, synthesis rates of hepatic secretory proteins, resting energy expenditure and substrate utilization, as well as circulating metabolites concentrations.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Colon Cancer
  • Dietary Supplement: Oral Nutrition with dextrose and pressurized whey protein
    Ten (10) subjects will be randomly assigned to receive an oral nutrition regimen comprised of 50% of their REE as dextrose and 20% of their REE as pressurized whey protein. Subjects will undergo a six-hour stable isotope infusion protocol one day before surgery (to obtain baseline data) and on the first post-operative day. During both infusion protocols, subjects will be asked to carry out their assigned oral nutrition regimen. To minimize fasting during the perioperative period all subjects will receive peripheral parenteral nutrition (PPN) at the time of surgical incision until the first postoperative day.
  • Dietary Supplement: Peripheral Parenteral Nutrition
    Ten (10) subjects will be randomly assigned to receive peripheral parenteral nutrition (PPN) regimen comprised of 50% of their REE as dextrose and 20% of their REE as amino acids. Subjects will undergo a six-hour stable isotope infusion protocol one day before surgery (to obtain baseline data) and on the first post-operative day. During both infusion protocols, subjects will be asked to carry out their assigned PPN regimen. To minimize fasting during the perioperative period all subjects will receive PPN at the time of surgical incision until the first postoperative day.
  • Active Comparator: Oral Nutrition
    Subjects will receive an oral nutrition regimen comprised of 50% of their Resting Energy Expenditure (REE) as dextrose and 20% of their REE as pressurized whey protein
    Intervention: Dietary Supplement: Oral Nutrition with dextrose and pressurized whey protein
  • Placebo Comparator: Peripheral Parenteral Nutrition
    Subjects will receive a peripheral parenteral nutrition (PPN) regimen comprised of 50% of their Resting Energy Expenditure (REE) as dextrose and 20% of their REE as amino acids.
    Intervention: Dietary Supplement: Peripheral Parenteral Nutrition
Schricker T, Meterissian S, Lattermann R, Adegoke OA, Marliss EB, Mazza L, Eberhart L, Carli F, Nitschman E, Wykes L. Anticatabolic effects of avoiding preoperative fasting by intravenous hypocaloric nutrition: a randomized clinical trial. Ann Surg. 2008 Dec;248(6):1051-9.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
20
November 2011
November 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  1. The American Society of Anesthesiologists' (ASA) class 1 to 3
  2. Colorectal surgery for non-metastatic disease (including right, transverse, left, sigmoid, subtotal, total, and hemicolectomy)
  3. Nutrition status: 18.5 < body mass index < 30 kg/m2, stable weight over the preceding three months (< 10% body weight loss), serum albumin > 35g/l

Exclusion Criteria:

  1. History of hepatic failure (Child-Pugh score A-C and transaminases outside the normal range)
  2. Renal impairment (Serum Creatinine outside normal range)
  3. Cardiac failure (New York Heart Association (NYHA) classes I-IV)
  4. Hepatic, Renal, Cardiac transplant
  5. Endocrine disorders: diabetes type I & II, hyper and hypothyroidism
  6. Active inflammatory bowel or diverticular disease (Crohn's Disease, Ulcerative Colitis)
  7. Musculoskeletal or neuromuscular disease
  8. Anemia defined as hematocrit < 30, hemoglobin < 10 g/dl, albumin < 25 mg/dl
  9. Previous spine surgery or scoliosis limiting use of epidural
  10. Pregnancy
  11. Use of Steroids
  12. Milk protein allergy or intolerance
Both
18 Years to 85 Years
No
Contact information is only displayed when the study is recruiting subjects
Canada
 
NCT01222208
10-106-GEN
No
Franco Carli, McGill University Health Center
McGill University Health Center
  • Montreal General Hospital
  • McGill University
Principal Investigator: Franco Carli, M.D. McGill University Health Center
McGill University Health Center
February 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP